Global Longlife Hospital stake falls to 6.89% in 2026

Key development at Global Longlife Hospital

A promoter-level share sale has been reported in Global Longlife Hospital and Research Limited, with filings indicating a sharp reduction in an individual promoter’s ownership. Dhruv Sureshkumar Jani, part of the promoter group, sold 10,00,000 equity shares through open market transactions on the BSE. The trades were executed over two sessions, between August 06 and August 07, 2026. Following the sale, his stake in the company dropped materially from 16.41% to 6.89% of the voting capital. The disclosure was made under Regulation 29(2) of SEBI’s (SAST) Regulations. The company’s shares are listed on BSE under scrip code 543520 and are categorised under Hospital and Healthcare Services.

What the SEBI filing says

The transaction was disclosed on August 08, 2026, under SEBI Regulation 29(2), which requires disclosure when promoter holdings cross specified thresholds due to buying or selling. The filing captures the mode of transaction as open market trades, and the dates of execution as August 06-07, 2026. It also shows the percentage change in holding: from 16.41% before the sale to 6.89% after the sale. The disclosure nature is important for investors because it formally documents promoter-group ownership changes that can affect market perception and governance tracking. While the filing does not state the rationale for the sale in the provided text, it establishes the quantum and timing of the divestment. It also creates continuity with earlier promoter transactions that were disclosed in prior months.

August 2026: 10,00,000 shares sold on BSE

Dhruv Sureshkumar Jani sold 10,00,000 equity shares of Global Longlife Hospital and Research Limited on the BSE between August 06 and August 07, 2026. The sale was executed via open market transactions. As a result of this sale, his promoter stake fell to 6.89% from 16.41%. The magnitude of the percentage decline signals a significant reduction in direct promoter holding in a short window. Because the trades happened on the exchange, the selling would have been absorbed by market participants across those sessions. The disclosure date of August 08, 2026 ties the transaction to the standard compliance timeline under SEBI rules. This update adds a new data point for tracking promoter ownership in the company.

July 2026: earlier sale of 6,78,000 shares

Before the August sale, the same promoter reported a sizeable open market divestment in July 2026. Dhruv Sureshkumar Jani sold 6,78,000 equity shares through open market trades between July 01 and July 30, 2026. The filing notes that his stake reduced from 22.87% to 16.41% following that sale. In share terms, the text states he held 24,00,990 shares before the transaction and 17,22,990 shares after the transaction. The disclosures also mention that the company’s total voting capital remained unchanged after the July sale. This makes the percentage reduction attributable to sale by the promoter rather than any change in the total number of shares.

January 2026: sale of 3,67,000 shares

The sequence of promoter reductions in 2026 also includes a sale in January. Dhruv Sureshkumar Jani sold 3,67,000 equity shares through open market transactions between January 6 and January 16, 2026. After the transaction, his shareholding decreased from 31.87% to 28.37%, as disclosed under SEBI Regulation 29(2) on January 20, 2026. The filing details in the text show a pre-sale holding of 33,45,990 shares and a post-sale holding of 29,78,990 shares. These numbers provide a clear audit trail of the promoter’s share count and percentage movement. Together with later July and August sales, they show multiple tranches of divestment over the year.

December 2025: promoter Sucheta Jani exits

Separate from Dhruv Jani’s transactions, the article text also references a complete exit by another promoter. Promoter Sucheta Dhruvkumar Jani sold her remaining 2,53,000 equity shares on December 26, 2025. This reduced her stake from 2.41% to 0.00%, indicating a full exit from the company. The disclosure for that transaction was filed on December 29, 2025 in compliance with SEBI Regulation 29(2). The mode of sale was open market. This event is relevant context because it indicates promoter-level churn prior to the 2026 transactions.

Share capital and promoter holding context

The company’s equity share capital is stated as ₹10.50 crore, based on 1,05,00,000 equity shares of ₹10 each. The text also notes that the total voting capital remained unchanged following the July sale. A separate snapshot in the provided content says promoter holding remained unchanged at 22.88% in the June 2026 quarter shareholding pattern. The same shareholding table shows promoter holding percentages moving across quarters, including 54.29% (Mar 2025), 54.90% (Jun 2025), 55.10% (Sep 2025), 35.44% (Dec 2025), and 22.88% (Mar 2026). The content also states promoter stake has been decreased from 35.44% to 22.88%. These figures are presented as part of the company’s disclosed shareholding pattern history, distinct from the individual promoter’s stake changes.

Stock price snapshots mentioned

The text includes multiple market snapshots. One quote shows the stock at ₹11.80 at 13:45 on 17-07-2026, up ₹0.40 (3.50%), with a previous close of ₹11.40; it also lists bid ₹11.05 (1000) and offer ₹11.79 (1000). Another update states Global Longlife Hospital and Research Ltd was trading at ₹11.78 as of 12:13, up 0.68%, with an intraday low of ₹11.78 and a high of ₹12.00. A separate line in the provided content states the current share price of Global Longlife Hosp is ₹10.18, with a BSE timestamp shown as 19 Jun 04:01 PM and a change of +0.10 (0.99%). These price points reflect different times and should be read as snapshots rather than a continuous series.

Timeline of disclosed promoter transactions

The following table summarises the promoter transactions explicitly described in the provided text.

Market impact and what investors typically track

Promoter selling is often tracked closely because it changes ownership concentration and can influence how investors interpret insider conviction and liquidity. In this case, the key measurable fact is the sharp reduction in Dhruv Sureshkumar Jani’s holding from 16.41% to 6.89% after the August 2026 sale of 10,00,000 shares. The text also establishes that his stake had already declined from 22.87% to 16.41% after the July 2026 sale of 6,78,000 shares, showing back-to-back reductions. For context, the company’s equity share capital is stated as ₹10.50 crore (1,05,00,000 shares of face value ₹10), and the voting capital is stated to have remained unchanged in the July disclosure. Investors typically compare such promoter-level moves with shareholding pattern data, such as the promoter holding figure of 22.88% referenced for the June 2026 quarter in the provided content. They also cross-check these disclosures with market trading snapshots, which here include prices such as ₹11.78-₹12.00 intraday range in one update, and ₹11.80 in another.

Conclusion

Global Longlife Hospital and Research Limited has reported another major promoter stake reduction, with Dhruv Sureshkumar Jani selling 10,00,000 shares on August 06-07, 2026 and bringing his holding down to 6.89% from 16.41%. The disclosed sequence also includes earlier sales in January and July 2026, and a complete promoter exit by Sucheta Dhruvkumar Jani in December 2025. The next concrete reference point for the market will be subsequent shareholding pattern disclosures and any further SEBI Regulation 29(2) filings that reflect additional changes in promoter ownership.